lecture 1 Flashcards

1
Q

what is target selection?

A

draggability of proteins —> enzyme, protein, signaling cascade?

criteria for evauluating potential small molecule drug targets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are most common drugs targeting?

A

small molecules & biologics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what makes a good target?
then what do we do? via?

A

disease with high unmet need– diabetes, cancer, depression

identify molecular drug target via phenotypic screening and biomarkers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how do we predict druggability? what is it?
what can structure be used to do?

A

based on high resolution structural info with know ligands

ability of likelyhood of being able to modulate target with small molecule

predict binding sites for small ligands & design small ligands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

most druggable proteins are those that ____?

A

have small molecule ligands or are

enzymes in the active site that we can have drug bind to

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the 4 main types of interactions with drugs and their targets?

A

charge interactions
and H bonds–> strong and reversible

hydrophobic interactions– > weak but drives affinity of molecule for target

covalent–> irreversible modifications, can cause immunogenicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

energetics of different ligand receptor binding interactions?

A

ionic–> salt bridge
ion-dipole
H bond
charge transfer
Vander Waals
hydrophobic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

is a large amount of energy need to obtain high binding affinity?

A

NO small favorable energy is needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are like gloves and what are like mittens?

A

gloves— small molecule- ligand binding sites

mittens– protein/ protein and protein/ DNA site are undraggable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is TPP?
what is it a critical component of?
precursor to it?

A

ideal properties of final desired product

living document by the drug discovery team

shows how product combats disease, use, efficiacy, target, administration

–Developemnt program (DP)
–TCP (target candidate profile)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the drug discovery and development pipeline?

A

drug discovery—> preclinical—> phase 1—> clinical phase 2—->phase 3—> approval

target selection–>
rational drug design—>
irrational drug design –>
target engagement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the magic bullet for syphillis?

A

salvarsan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how as penicillin first discovered?

A

using X ray crystallography in 1945

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what did the human genome contribute to drug discovery?

A

identify of thousands of potential drug targets

— sequenced human genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the most important aspect of drug discovery?

A

target selection !!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are most diseases?

A

usually polygenetic–> multiple genes involved

17
Q

what is target validation correlation does not establish causation?

A

does over expression cause disease? OR is over expression a good mechanism

OR is it coincidental

18
Q

a target is never ____ until the drug is _____?

A

validated until tested in humans

19
Q

many approaches to confirm successful manipulation of target will result in _________

A

diease relevant phenotype response

20
Q

what are weak interactions but can add up amount of binding energy?

A

charge transfer
vander walls
hydrophobic

21
Q

How do we validate our target?

A

Link gene to disease

Determine expression patterns between normal and not

Manipulate target

Elucidate disease pathways OR mechanisms of action